Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-090317
Filing Date
2024-08-05
Accepted
2024-08-05 07:19:05
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3956
  Complete submission text file 0000950170-24-090317.txt   5489
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ITEOS THERAPEUTICS, INC 321 ARSENAL ST BLDG 312, SUITE 301 WATERTOWN MA 02472
Business Address
Feltquate David (Reporting) CIK: 0002031518 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 241173093